Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A retrospective observational study of neuromuscular monitoring practice in 30,430 cases from six Danish hospitals

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Exploring the limits of prolonged apnoea with high-flow nasal oxygen: an observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Barriers and aidsto routine neuromuscular monitoring and consistent reversal practice: - a qualitative study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Minimising droplet and virus spread during and after tracheal extubation

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Muskelrelaxantia

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

  4. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Timely application of objective neuromuscular monitoring can avoid residual neuromuscular blockade. We assessed the frequency of objective neuromuscular monitoring with acceleromyography and the last recorded train-of-four ratio in a cohort of Danish patients. We extracted data from all patients receiving general anaesthesia from November 2014 to November 2016 at six hospitals in the Zealand Region of Denmark. Acceleromyography was available in all operating rooms and data were recorded automatically. The primary outcome measure was acceleromyography use in patients receiving neuromuscular blocking agents, divided into non-depolarising agents and succinylcholine only. The dataset included 76,743 cases, of which 30,430 received a neuromuscular blocking drug. Non-depolarising drugs were used in 16,525 (54%) and succinylcholine as the sole drug in 13,905 (46%) cases. Acceleromyography was used in 14,463 (88%) patients who received a non-depolarising neuromuscular blocking drug and in 4224 (30%) receiving succinylcholine alone. Acceleromyography use varied between the departments from 58% to 99% for non-depolarising drugs and from 3% to 79% for succinylcholine alone. The median (IQR [range]) of the last recorded train-of-four ratio before tracheal extubation was 0.97 (0.90–1.06 [0.01–2.20]) when non-depolarising drugs were used, and was less than 0.9 in 22% of cases. The OR for oxygen desaturation was higher with the use of succinylcholine [2.51 (95%CI 2.33–2.70) p < 0.001] and non-depolarising drugs [2.57 (95%CI 2.32–2.84) p < 0.001] as compared with cases where no neuromuscular blockade drug was used. In conclusion, acceleromyography was almost always used in cases where non-depolarising neuromuscular blocking drugs were used, but a train-of-four ratio of 0.9 was not always achieved. Monitoring was used in less than 30% of cases where succinylcholine was the sole drug used.

OriginalsprogEngelsk
TidsskriftAnaesthesia
Vol/bind75
Udgave nummer9
Sider (fra-til)1164-1172
Antal sider9
ISSN0003-2409
DOI
StatusUdgivet - 1 sep. 2020

Bibliografisk note

Funding Information:
We wish to thank the participating departments; J. Engbaek for invaluable help with designing the study; and J. Einarsson for assistance with programming the database. This work was supported by departmental resources, and grants from Minister Erna Hamilton's Legat for Videnskab og Kunst, Oberstinde Kirsten Jensa La Cours Forskningslegat and the Investigator‐Initiated Studies Program of Merck Sharp and Dohme Corp. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp and Dohme Corp. This study was registered at clinicaltrials.gov (NCT02914119). JT received research grants and speaker's fee from Merck. MG received research grants and speaker's fee from Merck. No other external funding or competing interests declared.

Funding Information:
We wish to thank the participating departments; J. Engbaek for invaluable help with designing the study; and J. Einarsson for assistance with programming the database. This work was supported by departmental resources, and grants from Minister Erna Hamilton's Legat for Videnskab og Kunst, Oberstinde Kirsten Jensa La Cours Forskningslegat and the Investigator-Initiated Studies Program of Merck Sharp and Dohme Corp. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp and Dohme Corp. This study was registered at clinicaltrials.gov (NCT02914119). JT received research grants and speaker's fee from Merck. MG received research grants and speaker's fee from Merck. No other external funding or competing interests declared.

Publisher Copyright:
© 2020 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

ID: 66206414